Twin Tree Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-9,700
Closed -$1.04M 1404
2019
Q4
$1.04M Buy
+9,700
New +$1.01M ﹤0.01% 856
2016
Q2
Sell
-3,500
Closed -$250K 1237
2016
Q1
$250K Sell
3,500
-7,700
-69% -$516K ﹤0.01% 961
2015
Q4
$797K Buy
+11,200
New +$753K 0.02% 712
2015
Q1
Sell
-3,800
Closed -$255K 1179
2014
Q4
$255K Buy
+3,800
New +$240K 0.01% 877

Other funds holding DGX

Twin Tree Management's DGX Position: Q4 2025 in Review

Twin Tree Management sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 2,850 shares — an estimated $543K sold.

Twin Tree Management first reported a position in DGX in Q1 2015 and held it in 21 quarters. The position peaked at $29.4M in Q4 2021. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • Twin Tree Management reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Twin Tree Management sold 2,850 Quest Diagnostics shares in Q4 2025, an estimated $543K.
  • Twin Tree Management first reported a position in Quest Diagnostics in Q1 2015 and held it in 21 quarters.
  • Twin Tree Management's Quest Diagnostics position peaked at $29.4M in Q4 2021.
  • 1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Twin Tree Management's 13F filing for Q4 2025, filed 11 Feb 2026.